Journal of wound careHumansUnited StatesMedicareUnited States Food and Drug AdministrationAged
Rethinking regulatory tiers: Medicare real-world evidence shows CAMP outcomes are independent of FDA regulatory classification.
William H Tettelbach, David G Armstrong, Travis Tucker, Thomas A Davenport, Lynnette A Morrison, David B Alper, Jonathan Johnson, Lee C Rogers, Jeffery A Niezgoda, Jennie Feight, Kevin Nolan, Daniel Kapp, Naz Wahab, Martha R Kelso
Published: 202610.12968/jowc.2025.0609
Abstract
OBJECTIVE: Cellular, acellular, and matrix-like products (CAMPs) are widely used for treating hard-to-heal lower-extremity diabetic ulcers (LEDUs) and venous leg ulcers (VLUs); yet, limited evidence exists to demonstrate that clinical outcomes differ…
Preview only. Read the full abstract at the source